Shaojing Ma
Managing Director @ China Venture Capital
Shaojing Ma is a Series A investor at China Venture Capital focused on Health Care and Therapeutics. Shaojing Ma
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Shaojing Ma invests in
Stages Shaojing Ma invests in
Countries Shaojing Ma invests in
Investment Focus
Industry
- Health Care 1 (50%)
- Therapeutics 1 (50%)
- Biotechnology 1 (50%)
- Pharmaceutical 1 (50%)
- Clinical Trials 1 (50%)
Stage
- Series A 1 (50%)
- Series B 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Alphamab Oncology
|
Alphamab Oncology is a clinical-stage biopharmaceutical company dedicated to the discovery, development manufacturing and commercialization of world-class innovative therapeutics for cancer treatment with multiple in-house proprietary platforms in bispecifics, protein engineering and antibody screening, Alphamab Oncology has built a robust pipelinein oncology/ immunology, and they are striving to develop next-generation or best-in-class medicines to address unmet medical needs globally. | $60M / Series B / May 28, 2019 | |
|
Alphamab Oncology
|
Alphamab Oncology is a clinical-stage biopharmaceutical company dedicated to the discovery, development manufacturing and commercialization of world-class innovative therapeutics for cancer treatment with multiple in-house proprietary platforms in bispecifics, protein engineering and antibody screening, Alphamab Oncology has built a robust pipelinein oncology/ immunology, and they are striving to develop next-generation or best-in-class medicines to address unmet medical needs globally. | $100M / Series A / Nov 16, 2018 |
Co-Investors
Advantech Capital
2 deals together
PAG
2 deals together
Heritage Provider Network
1 deal together
Janchor Partners
1 deal together
OrbiMed
1 deal together
About China Venture Capital
China Venture Capital is a venture capital industry trade group.
China Venture Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Chunsheng Huang
Senior Vice President
|
|||
|
Gu Bo
Chief Investment Officer
|
|||
|
Shaojing Ma
Managing Director
|
|||
2 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Shaojing Ma invest in?
Shaojing Ma invests primarily in Health Care, Therapeutics and Biotechnology startups, most often at Series A and Series B stage. Most of the 2 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Shaojing Ma last invest?
The most recent investment recorded for Shaojing Ma closed in May 2019. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
